MARLBOROUGH, MA—Qteros, a developer of next-generation technology solutions for the biofuels industry, has appointed Susan Hager as vice president of corporate communications and government affairs. Jef Sharp, senior vice president of corporate communications and government affairs, director and a member of the Qteros founding group, will continue to serve the Company as a member of Qteros’ board of directors.
Hager will report directly to John McCarthy, president and chief executive officer and will be responsible for leading all communications and government-related initiatives for the company, with an emphasis on building and enhancing Qteros’ positioning and brand within the industry.
Hager’s expertise includes corporate communications, investor relations, and media relations in support of complex product marketing and commercialization initiatives. She has considerable experience in advocacy relations and government affairs, specifically in developing and implementing communications programs to align influential advocacy groups and rally government support for various agency approvals and funding.
Prior to joining Qteros, Hager served as a director in the corporate communications and investor relations practice for WCG, a global healthcare communications agency. She has served previously as vice president, corporate communications and investor relations for Targanta Therapeutics (sold to The Medicines Company), as well as vice president, corporate communications, investor relations and corporate development for Coley Pharmaceutical Group (sold to Pfizer Inc). She has also held global marketing and communications roles with Bayer HealthCare.